Literature DB >> 28500908

Distress tolerance interacts with circumstances, motivation, and readiness to predict substance abuse treatment retention.

Bina Ali1, Kerry M Green2, Stacey B Daughters3, C W Lejuez4.   

Abstract

BACKGROUND: Our understanding of the conditions that influence substance abuse treatment retention in urban African American substance users is limited. This study examined the interacting effect of circumstances, motivation, and readiness (CMR) with distress tolerance to predict substance abuse treatment retention in a sample of urban African American treatment-seeking substance users.
METHODS: Data were collected from 81 African American substance users entering residential substance abuse treatment facility in an urban setting. Participants completed self-reported measures on CMR and distress tolerance. In addition, participants were assessed on psychiatric comorbidities, substance use severity, number of previous treatments, and demographic characteristics. Data on substance abuse treatment retention were obtained using administrative records of the treatment center.
RESULTS: Logistic regression analysis found that the interaction of CMR and distress tolerance was significant in predicting substance abuse treatment retention. Higher score on CMR was significantly associated with increased likelihood of treatment retention in substance users with higher distress tolerance, but not in substance users with lower distress tolerance.
CONCLUSIONS: Findings of the study indicate that at higher level of distress tolerance, favorable external circumstances, higher internal motivation, and greater readiness to treatment are important indicators of substance abuse treatment retention. The study highlights the need for assessing CMR and distress tolerance levels among substance users entering treatment, and providing targeted interventions to increase substance abuse treatment retention and subsequent recovery from substance abuse among urban African American substance users.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Minority; Residential treatment dropout; Stages of change; Substance use disorders; Treatment completion

Mesh:

Year:  2017        PMID: 28500908      PMCID: PMC5542844          DOI: 10.1016/j.addbeh.2017.04.016

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  31 in total

Review 1.  Post-hoc probing of significant moderational and mediational effects in studies of pediatric populations.

Authors:  Grayson N Holmbeck
Journal:  J Pediatr Psychol       Date:  2002 Jan-Feb

2.  Treatment motivation and therapeutic engagement in prison-based substance use treatment.

Authors:  Paul J Rosen; Matthew L Hiller; J Matthew Webster; Michele Staton; Carl Leukefeld
Journal:  J Psychoactive Drugs       Date:  2004-09

3.  The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability.

Authors:  J B Williams; M Gibbon; M B First; R L Spitzer; M Davies; J Borus; M J Howes; J Kane; H G Pope; B Rounsaville
Journal:  Arch Gen Psychiatry       Date:  1992-08

Review 4.  Impulsivity as a common process across borderline personality and substance use disorders.

Authors:  Marina A Bornovalova; C W Lejuez; Stacey B Daughters; M Zachary Rosenthal; Thomas R Lynch
Journal:  Clin Psychol Rev       Date:  2005-09

5.  Prevalence of substance use disorders among African Americans and Caribbean Blacks in the National Survey of American Life.

Authors:  Clifford L Broman; Harold W Neighbors; Jorge Delva; Myriam Torres; James S Jackson
Journal:  Am J Public Health       Date:  2007-10-30       Impact factor: 9.308

6.  The role of distress tolerance in the relationship between depressive symptoms and problematic alcohol use.

Authors:  Stephanie M Gorka; Bina Ali; Stacey B Daughters
Journal:  Psychol Addict Behav       Date:  2011-11-28

7.  The impact of borderline personality disorder on residential substance abuse treatment dropout among men.

Authors:  Matthew T Tull; Kim L Gratz
Journal:  Drug Alcohol Depend       Date:  2011-09-09       Impact factor: 4.492

8.  Mindfulness-based relapse prevention for substance use disorders: a pilot efficacy trial.

Authors:  Sarah Bowen; Neharika Chawla; Susan E Collins; Katie Witkiewitz; Sharon Hsu; Joel Grow; Seema Clifasefi; Michelle Garner; Anne Douglass; Mary E Larimer; Alan Marlatt
Journal:  Subst Abus       Date:  2009 Oct-Dec       Impact factor: 3.716

9.  Personality disorders in drug abusers: prevalence and their association with AXIS I disorders as predictors of treatment retention.

Authors:  A Kokkevi; N Stefanis; E Anastasopoulou; C Kostogianni
Journal:  Addict Behav       Date:  1998 Nov-Dec       Impact factor: 3.913

10.  Anxiety sensitivity: a unique predictor of dropout among inner-city heroin and crack/cocaine users in residential substance use treatment.

Authors:  C W Lejuez; Michael J Zvolensky; Stacey B Daughters; Marina A Bornovalova; Autumn Paulson; Matthew T Tull; Kenneth Ettinger; Michael W Otto
Journal:  Behav Res Ther       Date:  2008-03-28
View more
  4 in total

1.  Moment-by-Moment in Women's Recovery (MMWR): Mindfulness-based intervention effects on residential substance use disorder treatment retention in a randomized controlled trial.

Authors:  David S Black; Hortensia Amaro
Journal:  Behav Res Ther       Date:  2019-07-07

2.  Levels of distress tolerance in schizophrenia appear equivalent to those found in borderline personality disorder.

Authors:  Kelsey A Bonfils; Paul H Lysaker
Journal:  J Clin Psychol       Date:  2020-02-18

3.  An examination of abstinence social support among recovery home residents with psychiatric comorbidity.

Authors:  John M Majer; Leonard A Jason; Ted J Bobak
Journal:  Drug Alcohol Depend       Date:  2021-09-08       Impact factor: 4.492

4.  What motivates people with substance use disorders to pursue treatment? A patient-centered approach to understanding patient experiences and patient-provider interactions.

Authors:  Laura E Gressler; Nabil M Natafgi; Bruce R DeForge; Barbarajean Shaneman-Robinson; Christopher Welsh; Fadia T Shaya
Journal:  J Subst Use       Date:  2019-07-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.